Pharmaceutical - Inflammatory diseases, Vaccines

Filter

Popular Filters

Licensing deals for Philogen with Pfizer and GlycoVaxyn with Janssen

07-01-2013

Privately held Italian biopharma firm Philogen SpA (Siena, Italy) has granted global drugs behemoth Pfizer…

BiotechnologyDekavilGlycoVaxynInflammatory diseasesJanssenJohnson & JohnsonLicensingPfizerPharmaceuticalPhilogenVaccines

EMA reviews hypothesis on Pandemrix hypothesis; finalizes on NSAIDs and CV events

21-10-2012

The European Medicines Agency's Committee on Human Medicinal Products (CHMP) said Friday that it has…

Anti-Arthritics/RheumaticsdiclofenacGlaxoSmithKlineibuprofenInflammatory diseasesNaproxenNeurologicalPandemrixPharmaceuticalRegulationVaccines

Takeda acquires vaccine maker LigoCyte; signs multi-drug discovery deal with Advinus

05-10-2012

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) says it is to acquire privately-held US vaccine…

Advinus TherapeuticsInflammatory diseasesLicensingLigoCyteMergers & AcquisitionsMetabolicsNeurologicalPharmaceuticalTakeda PharmaceuticalsVaccines

Back to top